Targeting Human Retinoblastoma Binding Protein 4 (RBBP4) and 7 (RBBP7)
Abstract
RBBP4 and RBBP7 (RBBP4/7) are highly homologous nuclear WD40 motif containing proteins widely implicated in various cancers and are valuable drug targets. They interact with multiple proteins within diverse complexes such as NuRD and PRC2, as well as histone H3 and H4 through two distinct binding sites. FOG-1, PHF6 and histone H3 bind to the top of the donut shape seven-bladed {beta}-propeller fold, while SUZ12, MTA1 and histone H4 bind to a pocket on the side of the WD40 repeats. Here, we briefly review these six interactions and present binding assays optimized for medium to high throughput screening. These assays enable screening of RBBP4/7 toward the discovery of novel cancer therapeutics.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery of small molecule antagonists of human Retinoblastoma Binding Protein 4 (RBBP4)
S. Perveen, C. A. Zepeda-Velazquez, … M. Vedadi·bioRxiv·Jan 5, 2022
- rec-Y2H matrix screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins
B. Lang, J.-S. Yang, … S. P. Maurer·bioRxiv·Sep 14, 2020
- Structural basis for tunable affinity and specificity of LxCxEdependentprotein interactions with the retinoblastoma protein family
S. Putta, L. Alvarez, … S. Rubin·bioRxiv·Jun 10, 2022
- Crystal structure of chromo barrel domain of RBBP1
- Functional characterization of RebL1 highlights the evolutionary conservation of oncogenic activities of the RBBP4/7 orthologue in Tetrahymena thermophila
Syed Nabeel‐Shah, Jyoti Garg, … Jeffrey Fillingham·Nucleic Acids ResearchPeer-reviewed·May 4, 2021
- RSPO2-based peptibodies conjugated with pyrrolobenzodiazepine dimer or camptothecin analogs demonstrate potent anti-tumor activity by targeting the three receptors LGR4/5/6 in colorectal cancer and neuroblastoma
Yukimatsu Toh, Jianghua Tu, … Qingyun J. Liu·Journal of Medicinal ChemistryPeer-reviewed·Apr 9, 2026